Cargando…

Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis

BACKGROUND: Cytomegalovirus infection is one of the most common complications after solid organ transplantation. There have been several classes of antiviral drugs for the prevention of cytomegalovirus infection, such as acyclovir, valacyclovir, ganciclovir and valganciclovir. METHODS: We searched r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yu, Zhou, Tao, Huang, Mingzhu, Gu, Guangxiang, Xia, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409489/ https://www.ncbi.nlm.nih.gov/pubmed/32758225 http://dx.doi.org/10.1186/s12941-020-00372-0

Ejemplares similares

2740. Letermovir for the Prevention and Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients
por: Xhemali, Xhilda, et al.
Publicado: (2023)

Cytomegalovirus Infections in Solid Organ Transplantation: A Review
por: Ramanan, Poornima, et al.
Publicado: (2013)

Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands
por: Van Leer Buter, Coretta C, et al.
Publicado: (2019)

Combination of Neoadjuvant Therapy and Liver Transplantation in Pediatric Multisystem Langerhans Cell Histiocytosis With Liver Involvement
por: Chen, Chen, et al.
Publicado: (2020)

Laboratory diagnostic testing for cytomegalovirus infection in solid organ transplant patients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant
por: Higdon, Lauren E., et al.
Publicado: (2021)

Innate Immune Cells in Immune Tolerance After Liver Transplantation
por: Huang, Hongting, et al.
Publicado: (2018)

Infection Prevention and Control Issues After Solid Organ Transplantation
por: Banach, David B., et al.
Publicado: (2016)

Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy
por: Kalil, Andre C., et al.
Publicado: (2009)

1079. The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis
por: Wu, Yue, et al.
Publicado: (2020)

1750. Epidemiology of Cytomegalovirus DNAemia in Pediatric Solid-Organ Transplant Patients
por: Valencia Deray, Kristen, et al.
Publicado: (2019)

Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation
por: Emery, Vincent C., et al.
Publicado: (2012)

Are the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
por: Rafferty, Hannah, et al.
Publicado: (2022)

Mental health in children with living donor liver transplantation: a propensity score-matched analysis
por: Huang, Mingzhu, et al.
Publicado: (2022)

Characterization of Cytomegalovirus Disease in Solid Organ Transplant Recipients by Markers of Inflammation in Plasma
por: Rollag, Halvor, et al.
Publicado: (2013)

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
por: Atabani, S F, et al.
Publicado: (2012)

Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients
por: Maggi, Fabrizio, et al.
Publicado: (2018)

Unusual Manifestations of Acute Cytomegalovirus Infection in Solid Organ Transplant Hosts: A Report of Two Cases
por: Mena Lora, Alfredo, et al.
Publicado: (2017)

Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection
por: Tamzali, Yanis, et al.
Publicado: (2023)

Cytomegalovirus infection after liver transplantation
por: Lizaola-Mayo, Blanca C, et al.
Publicado: (2020)

Cytomegalovirus infection after renal transplantation
por: Al Atbee, Mohammed Younus Naji, et al.
Publicado: (2022)

Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea
por: La, Yeonju, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity
por: van der Wekken-Pas, Lena C., et al.
Publicado: (2023)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
por: Vaziri, Siavash, et al.
Publicado: (2014)

Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation
por: Lumley, Sheila, et al.
Publicado: (2019)

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
por: Khurana, Mark P, et al.
Publicado: (2019)

Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland
por: Walti, Laura N., et al.
Publicado: (2023)

Prevention and management of CMV infection in pediatric solid organ transplant recipients
por: Balani, Shanthi S., et al.
Publicado: (2023)

Prevention and Treatment of Infectious Complications After Solid Organ Transplantation in Children
por: Allen, Upton, et al.
Publicado: (2010)

Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies
por: Han, Sang Hoon
Publicado: (2017)

1579. Evaluation of MATCH: an Electronic Individual Patient-Focused Management System Aimed at Preventing Cytomegalovirus Disease Following Solid Organ Transplantation
por: Ekenberg, Christina, et al.
Publicado: (2018)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

Cryptosporidium infection in solid organ transplantation
por: Florescu, Diana F, et al.
Publicado: (2016)

Infections in Solid-Organ Transplant Recipients
por: Singh, Nina, et al.
Publicado: (2015)

Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation
por: Grossi, Paolo Antonio, et al.
Publicado: (2022)

Cytomegalovirus infection in immunosuppressed patients after kidney transplantation
por: LUSCALOV, SIMONA, et al.
Publicado: (2016)

Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation
por: Litjens, Nicolle H. R., et al.
Publicado: (2018)

Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
por: Wang, Nan, et al.
Publicado: (2017)

1702. Assessing the Safety and Efficacy of Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients on Hemodialysis
por: Yee, Jason, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gg78gh79v3ictk7agq7jh0qs45